Covington Advises Underwriters in $55 Million Public Offering by Trevi Therapeutics

Covington Advises Underwriters in $55 Million Public Offering by Trevi Therapeutics

September 22, 2022

NEW YORK—Covington represented the underwriters in Trevi Therapeutics, Inc.'s $55 million public offering.

Trevi Therapeutics issued and sold 14,252,670 shares of its common stock and pre-funded warrants to purchase 14,247,330 shares of common stock in the public offering.

The Securities and Capital Markets team included Brian K. Rosenzweig, Julie Plyler, Mark Edlund, and Montene Speight. Assistance was also provided by Peter Safir (regulatory), Melody Wu and Jennifer Robbins (intellectual property), Matthew Gehl (legal opinion), Kurt Baca (tax), and Marianne McKeon (FINRA and Blue Sky).